DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr |
What is the latest Short Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹850 Cr |
| Mar2024 | ₹527 Cr |
| Mar2023 | ₹445 Cr |
| Mar2022 | ₹1,265 Cr |
| Mar2021 | ₹624 Cr |
How is Short Term Provisions of DIVIS LABORATORIES Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹850 Cr | 61.29 | |
| Mar2024 | ₹527 Cr | 18.43 | |
| Mar2023 | ₹445 Cr | -64.81 | |
| Mar2022 | ₹1,265 Cr | 102.56 | |
| Mar2021 | ₹624 Cr | - | |
Compare Short Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,492.6 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹104,535.0 Cr | 1.8% | 6.7% | 8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3% |
2.8% |
0.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses